Speciality Pharmaceutical Market Report

Europe Speciality Pharmaceutical Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 16, 2019
  • PAGES：194
  • REPORT CODE：GMM325014
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Speciality Pharmaceutical market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Speciality Pharmaceutical Market Segmentations:

    By Player:

    • King Pharmaceutical

    • Purdue Pharma

    • SEP

    • Allergan

    • Mundipharma

    • Luqa Pharma

    • Matrix (CN)

    • Biogen idec

    • Endo

    • Sun Pharma

    • Tevu Pharma

    • East China Pharma

    • Gilead sciences

    • Servier

    • Lundbeck

    • Methapharm

    • Forest

    • Mallinckrodt

    • UCB

    • Actavis

    • Alcon

    • BTG

    • Shire

    • Luye Pharma Group

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Speciality Pharmaceutical Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Speciality Pharmaceutical Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Speciality Pharmaceutical Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Speciality Pharmaceutical Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Speciality Pharmaceutical Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Speciality Pharmaceutical Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Speciality Pharmaceutical Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Speciality Pharmaceutical Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Speciality Pharmaceutical by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Speciality Pharmaceutical Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Speciality Pharmaceutical by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Speciality Pharmaceutical for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Speciality Pharmaceutical for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Speciality Pharmaceutical for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Speciality Pharmaceutical Production Analysis by Top Regions

    • 5.2 Europe Speciality Pharmaceutical Consumption Analysis by Top Regions

    • 5.3 Europe Speciality Pharmaceutical Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.3 France Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    6 Product Circulation of Speciality Pharmaceutical Market among Top Countries

    • 6.1 Top 5 Export Countries in Speciality Pharmaceutical Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Speciality Pharmaceutical Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Speciality Pharmaceutical Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Speciality Pharmaceutical Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Speciality Pharmaceutical Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Speciality Pharmaceutical Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Speciality Pharmaceutical Landscape Analysis

    • 7.1 Germany Speciality Pharmaceutical Landscape Analysis by Major Types

    • 7.2 Germany Speciality Pharmaceutical Landscape Analysis by Major End-Users

    8. UK Speciality Pharmaceutical Landscape Analysis

    • 8.1 UK Speciality Pharmaceutical Landscape Analysis by Major Types

    • 8.2 UK Speciality Pharmaceutical Landscape Analysis by Major End-Users

    9. France Speciality Pharmaceutical Landscape Analysis

    • 9.1 France Speciality Pharmaceutical Landscape Analysis by Major Types

    • 9.2 France Speciality Pharmaceutical Landscape Analysis by Major End-Users

    10. Italy Speciality Pharmaceutical Landscape Analysis

    • 10.1 Italy Speciality Pharmaceutical Landscape Analysis by Major Types

    • 10.2 Italy Speciality Pharmaceutical Landscape Analysis by Major End-Users

    11. Spain Speciality Pharmaceutical Landscape Analysis

    • 11.1 Spain Speciality Pharmaceutical Landscape Analysis by Major Types

    • 11.2 Spain Speciality Pharmaceutical Landscape Analysis by Major End-Users

    12. Poland Speciality Pharmaceutical Landscape Analysis

    • 12.1 Poland Speciality Pharmaceutical Landscape Analysis by Major Types

    • 12.2 Poland Speciality Pharmaceutical Landscape Analysis by Major End-Users

    13. Russia Speciality Pharmaceutical Landscape Analysis

    • 13.1 Russia Speciality Pharmaceutical Landscape Analysis by Major Types

    • 13.2 Russia Speciality Pharmaceutical Landscape Analysis by Major End-Users

    14. Switzerland Speciality Pharmaceutical Landscape Analysis

    • 14.1 Switzerland Speciality Pharmaceutical Landscape Analysis by Major Types

    • 14.2 Switzerland Speciality Pharmaceutical Landscape Analysis by Major End-Users

    15. Turkey Speciality Pharmaceutical Landscape Analysis

    • 15.1 Turkey Speciality Pharmaceutical Landscape Analysis by Major Types

    • 15.2 Turkey Speciality Pharmaceutical Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Landscape Analysis by Top Countries

      • 16.3.1 Denmark Speciality Pharmaceutical Market Volume and Growth Rate

      • 16.3.2 Finland Speciality Pharmaceutical Market Volume and Growth Rate

      • 16.3.3 Norway Speciality Pharmaceutical Market Volume and Growth Rate

      • 16.3.4 Sweden Speciality Pharmaceutical Market Volume and Growth Rate

      • 16.3.6 Iceland Speciality Pharmaceutical Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Landscape Analysis by Top Countries

      • 17.3.1 Belgium Speciality Pharmaceutical Market Volume and Growth Rate

      • 17.3.2 Netherlands Speciality Pharmaceutical Market Volume and Growth Rate

      • 17.3.3 Luxembourg Speciality Pharmaceutical Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Landscape Analysis by Top Countries

      • 18.3.1 Estonia Speciality Pharmaceutical Market Volume and Growth Rate

      • 18.3.2 Latvia Speciality Pharmaceutical Market Volume and Growth Rate

      • 18.3.3 Lithuania Speciality Pharmaceutical Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 King Pharmaceutical

      • 19.1.1 King Pharmaceutical Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Purdue Pharma

      • 19.2.1 Purdue Pharma Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 SEP

      • 19.3.1 SEP Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Allergan

      • 19.4.1 Allergan Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Mundipharma

      • 19.5.1 Mundipharma Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Luqa Pharma

      • 19.6.1 Luqa Pharma Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Matrix (CN)

      • 19.7.1 Matrix (CN) Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Biogen idec

      • 19.8.1 Biogen idec Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Endo

      • 19.9.1 Endo Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Sun Pharma

      • 19.10.1 Sun Pharma Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Tevu Pharma

      • 19.11.1 Tevu Pharma Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 East China Pharma

      • 19.12.1 East China Pharma Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Gilead sciences

      • 19.13.1 Gilead sciences Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Servier

      • 19.14.1 Servier Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Lundbeck

      • 19.15.1 Lundbeck Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Methapharm

      • 19.16.1 Methapharm Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Forest

      • 19.17.1 Forest Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Mallinckrodt

      • 19.18.1 Mallinckrodt Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 UCB

      • 19.19.1 UCB Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Actavis

      • 19.20.1 Actavis Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Alcon

      • 19.21.1 Alcon Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 BTG

      • 19.22.1 BTG Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Shire

      • 19.23.1 Shire Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Luye Pharma Group

      • 19.24.1 Luye Pharma Group Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    The List of Tables and Figures (Totals 87 Figures and 121 Tables)

    • Figure Product Picture

    • Figure Europe Speciality Pharmaceutical Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Speciality Pharmaceutical Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Speciality Pharmaceutical Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Speciality Pharmaceutical Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Speciality Pharmaceutical Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Speciality Pharmaceutical Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure UK Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure France Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Speciality Pharmaceutical Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Speciality Pharmaceutical Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Speciality Pharmaceutical

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Speciality Pharmaceutical by Different Types from 2014 to 2026

    • Table Consumption Share of Speciality Pharmaceutical by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Speciality Pharmaceutical by Different End-Users from 2014 to 2026

    • Table Consumption Share of Speciality Pharmaceutical by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Speciality Pharmaceutical Production by Major Regions

    • Table Europe Speciality Pharmaceutical Production Share by Major Regions

    • Figure Europe Speciality Pharmaceutical Production Share by Major Countries and Regions in 2014

    • Table Europe Speciality Pharmaceutical Consumption by Major Regions

    • Table Europe Speciality Pharmaceutical Consumption Share by Major Regions

    • Table Germany Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table UK Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table France Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Italy Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Spain Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Poland Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Russia Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Switzerland Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Turkey Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Speciality Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Speciality Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Speciality Pharmaceutical Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Speciality Pharmaceutical Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Germany Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Germany Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Germany Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table UK Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table UK Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table UK Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table UK Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table France Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table France Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table France Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table France Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Italy Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Italy Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Italy Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Italy Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Spain Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Spain Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Spain Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Spain Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Poland Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Poland Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Poland Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Poland Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Russia Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Russia Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Russia Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Russia Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Switzerland Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Switzerland Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Switzerland Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Turkey Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Turkey Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Turkey Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Speciality Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Speciality Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Speciality Pharmaceutical Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Speciality Pharmaceutical Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of King Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of King Pharmaceutical

    • Figure Sales and Growth Rate Analysis of King Pharmaceutical

    • Figure Revenue and Market Share Analysis of King Pharmaceutical

    • Table Product and Service Introduction of King Pharmaceutical

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of SEP

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SEP

    • Figure Sales and Growth Rate Analysis of SEP

    • Figure Revenue and Market Share Analysis of SEP

    • Table Product and Service Introduction of SEP

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Mundipharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma

    • Figure Sales and Growth Rate Analysis of Mundipharma

    • Figure Revenue and Market Share Analysis of Mundipharma

    • Table Product and Service Introduction of Mundipharma

    • Table Company Profile and Development Status of Luqa Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luqa Pharma

    • Figure Sales and Growth Rate Analysis of Luqa Pharma

    • Figure Revenue and Market Share Analysis of Luqa Pharma

    • Table Product and Service Introduction of Luqa Pharma

    • Table Company Profile and Development Status of Matrix (CN)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Matrix (CN)

    • Figure Sales and Growth Rate Analysis of Matrix (CN)

    • Figure Revenue and Market Share Analysis of Matrix (CN)

    • Table Product and Service Introduction of Matrix (CN)

    • Table Company Profile and Development Status of Biogen idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen idec

    • Figure Sales and Growth Rate Analysis of Biogen idec

    • Figure Revenue and Market Share Analysis of Biogen idec

    • Table Product and Service Introduction of Biogen idec

    • Table Company Profile and Development Status of Endo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo

    • Figure Sales and Growth Rate Analysis of Endo

    • Figure Revenue and Market Share Analysis of Endo

    • Table Product and Service Introduction of Endo

    • Table Company Profile and Development Status of Sun Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharma

    • Figure Sales and Growth Rate Analysis of Sun Pharma

    • Figure Revenue and Market Share Analysis of Sun Pharma

    • Table Product and Service Introduction of Sun Pharma

    • Table Company Profile and Development Status of Tevu Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tevu Pharma

    • Figure Sales and Growth Rate Analysis of Tevu Pharma

    • Figure Revenue and Market Share Analysis of Tevu Pharma

    • Table Product and Service Introduction of Tevu Pharma

    • Table Company Profile and Development Status of East China Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of East China Pharma

    • Figure Sales and Growth Rate Analysis of East China Pharma

    • Figure Revenue and Market Share Analysis of East China Pharma

    • Table Product and Service Introduction of East China Pharma

    • Table Company Profile and Development Status of Gilead sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead sciences

    • Figure Sales and Growth Rate Analysis of Gilead sciences

    • Figure Revenue and Market Share Analysis of Gilead sciences

    • Table Product and Service Introduction of Gilead sciences

    • Table Company Profile and Development Status of Servier

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Servier

    • Figure Sales and Growth Rate Analysis of Servier

    • Figure Revenue and Market Share Analysis of Servier

    • Table Product and Service Introduction of Servier

    • Table Company Profile and Development Status of Lundbeck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lundbeck

    • Figure Sales and Growth Rate Analysis of Lundbeck

    • Figure Revenue and Market Share Analysis of Lundbeck

    • Table Product and Service Introduction of Lundbeck

    • Table Company Profile and Development Status of Methapharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Methapharm

    • Figure Sales and Growth Rate Analysis of Methapharm

    • Figure Revenue and Market Share Analysis of Methapharm

    • Table Product and Service Introduction of Methapharm

    • Table Company Profile and Development Status of Forest

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Forest

    • Figure Sales and Growth Rate Analysis of Forest

    • Figure Revenue and Market Share Analysis of Forest

    • Table Product and Service Introduction of Forest

    • Table Company Profile and Development Status of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Company Profile and Development Status of UCB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB

    • Figure Sales and Growth Rate Analysis of UCB

    • Figure Revenue and Market Share Analysis of UCB

    • Table Product and Service Introduction of UCB

    • Table Company Profile and Development Status of Actavis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

    • Figure Sales and Growth Rate Analysis of Actavis

    • Figure Revenue and Market Share Analysis of Actavis

    • Table Product and Service Introduction of Actavis

    • Table Company Profile and Development Status of Alcon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alcon

    • Figure Sales and Growth Rate Analysis of Alcon

    • Figure Revenue and Market Share Analysis of Alcon

    • Table Product and Service Introduction of Alcon

    • Table Company Profile and Development Status of BTG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BTG

    • Figure Sales and Growth Rate Analysis of BTG

    • Figure Revenue and Market Share Analysis of BTG

    • Table Product and Service Introduction of BTG

    • Table Company Profile and Development Status of Shire

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire

    • Figure Sales and Growth Rate Analysis of Shire

    • Figure Revenue and Market Share Analysis of Shire

    • Table Product and Service Introduction of Shire

    • Table Company Profile and Development Status of Luye Pharma Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Luye Pharma Group

    • Figure Sales and Growth Rate Analysis of Luye Pharma Group

    • Figure Revenue and Market Share Analysis of Luye Pharma Group

    • Table Product and Service Introduction of Luye Pharma Group

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US